Serum lipids in patients with chronic renal failure on long-term, protein-restricted diets
- PMID: 2486548
Serum lipids in patients with chronic renal failure on long-term, protein-restricted diets
Abstract
Disordered lipid metabolism is believed to play an important role in accelerating the progression of chronic renal disease toward uremia. We examine this hypothetic role of lipids in a large population of patients on long-term dietary protein restriction. In our experience, there is no conclusive evidence that lipids may accelerate the progression of functional deterioration in patients with reduced renal function. Hyperlipidemia seems to be only one among the many factors affecting the prognosis of primary renal disease. Dietary protein restriction is effective in maintaining normal or only slightly elevated serum lipid levels in patients with early renal failure. Moreover, patients with renal failure maintained on this diet, which provides an elevated ratio of polyunsaturated to saturated fatty acids, have a more favorable lipid composition of erythrocyte membrane (low percentage of saturated fatty acids and high percentage of polyunsaturated fatty acids) when compared with patients on an unrestricted diet.
Similar articles
-
Effect of dietary manipulation on the lipid abnormalities in patients with chronic renal failure.Kidney Int Suppl. 1991 Apr;31:S70-2. Kidney Int Suppl. 1991. PMID: 2046274 Review.
-
Modification of serum and membrane lipid composition induced by diet in patients with chronic renal failure.Clin Nephrol. 1990 Dec;34(6):267-71. Clin Nephrol. 1990. PMID: 2073770
-
Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients.J Ren Nutr. 2009 Sep;19(5):401-11. doi: 10.1053/j.jrn.2009.04.006. Epub 2009 Jun 21. J Ren Nutr. 2009. PMID: 19541503 Clinical Trial.
-
Diet and coronary heart disease.Hum Nutr Clin Nutr. 1982;36(6):413-27. Hum Nutr Clin Nutr. 1982. PMID: 6298152 Review.
-
Role of lipids in the progression of renal disease in chronic renal failure: evidence from animal studies and pathogenesis.Isr J Med Sci. 1993 Apr;29(4):228-39. Isr J Med Sci. 1993. PMID: 8491578 Review.
Cited by
-
The dipeptidyl peptidase-4 inhibitor sitagliptin protects against dyslipidemia-related kidney injury in Apolipoprotein E knockout mice.Int J Mol Sci. 2014 Jun 26;15(7):11416-34. doi: 10.3390/ijms150711416. Int J Mol Sci. 2014. PMID: 24972137 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical